Production of human immunoglobulin G reactive against human cancer in tumor-bearing mice with severe combined immunodeficiency reconstituted with human splenic tissues

Toshiharu Furukawa, Masahiko Watanabe, Tetsuro Kubota, Hiroshi Yamaguchi, Tatsuo Teramoto, Kyuya Ishibiki, Masaki Kitajima

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Splenic tissues derived from patients with gastric cancer were implanted into mice with severe combined immunodeficiency (SCID) and then the mice were challenged with COLO-205, a human colon cancer cell line. Production of human immunoglobulin G (IgG) reactive against the COLO-205 cells was detected by enzyme-linked immunosorbent assay in sera from the reconstituted and tumor-bearing SCID mice. The titers of the reactive IgG relative to total IgG in the sera of SCID mice began to increase from one week after implantation of the tumor cells, and became 10- to 100-fold higher than that in the donor's serum by 3-4 weeks. This model using implantation of human cancer cells in SCID mice reconstituted with human splenic tissues would facilitate further studies of human cancer immunology.

Original languageEnglish
Pages (from-to)894-898
Number of pages5
JournalJapanese Journal of Cancer Research
Volume83
Issue number8
Publication statusPublished - 1992 Aug

Fingerprint

Severe Combined Immunodeficiency
Immunoglobulin G
Neoplasms
Serum
Allergy and Immunology
Colonic Neoplasms
Stomach Neoplasms
Enzyme-Linked Immunosorbent Assay
Tissue Donors
Cell Line

Keywords

  • Human immunoglobulin
  • SCID mouse
  • Splenic tissue

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Production of human immunoglobulin G reactive against human cancer in tumor-bearing mice with severe combined immunodeficiency reconstituted with human splenic tissues. / Furukawa, Toshiharu; Watanabe, Masahiko; Kubota, Tetsuro; Yamaguchi, Hiroshi; Teramoto, Tatsuo; Ishibiki, Kyuya; Kitajima, Masaki.

In: Japanese Journal of Cancer Research, Vol. 83, No. 8, 08.1992, p. 894-898.

Research output: Contribution to journalArticle

Furukawa, Toshiharu ; Watanabe, Masahiko ; Kubota, Tetsuro ; Yamaguchi, Hiroshi ; Teramoto, Tatsuo ; Ishibiki, Kyuya ; Kitajima, Masaki. / Production of human immunoglobulin G reactive against human cancer in tumor-bearing mice with severe combined immunodeficiency reconstituted with human splenic tissues. In: Japanese Journal of Cancer Research. 1992 ; Vol. 83, No. 8. pp. 894-898.
@article{ed3ae58629674ca780349c46ace9ab5f,
title = "Production of human immunoglobulin G reactive against human cancer in tumor-bearing mice with severe combined immunodeficiency reconstituted with human splenic tissues",
abstract = "Splenic tissues derived from patients with gastric cancer were implanted into mice with severe combined immunodeficiency (SCID) and then the mice were challenged with COLO-205, a human colon cancer cell line. Production of human immunoglobulin G (IgG) reactive against the COLO-205 cells was detected by enzyme-linked immunosorbent assay in sera from the reconstituted and tumor-bearing SCID mice. The titers of the reactive IgG relative to total IgG in the sera of SCID mice began to increase from one week after implantation of the tumor cells, and became 10- to 100-fold higher than that in the donor's serum by 3-4 weeks. This model using implantation of human cancer cells in SCID mice reconstituted with human splenic tissues would facilitate further studies of human cancer immunology.",
keywords = "Human immunoglobulin, SCID mouse, Splenic tissue",
author = "Toshiharu Furukawa and Masahiko Watanabe and Tetsuro Kubota and Hiroshi Yamaguchi and Tatsuo Teramoto and Kyuya Ishibiki and Masaki Kitajima",
year = "1992",
month = "8",
language = "English",
volume = "83",
pages = "894--898",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Production of human immunoglobulin G reactive against human cancer in tumor-bearing mice with severe combined immunodeficiency reconstituted with human splenic tissues

AU - Furukawa, Toshiharu

AU - Watanabe, Masahiko

AU - Kubota, Tetsuro

AU - Yamaguchi, Hiroshi

AU - Teramoto, Tatsuo

AU - Ishibiki, Kyuya

AU - Kitajima, Masaki

PY - 1992/8

Y1 - 1992/8

N2 - Splenic tissues derived from patients with gastric cancer were implanted into mice with severe combined immunodeficiency (SCID) and then the mice were challenged with COLO-205, a human colon cancer cell line. Production of human immunoglobulin G (IgG) reactive against the COLO-205 cells was detected by enzyme-linked immunosorbent assay in sera from the reconstituted and tumor-bearing SCID mice. The titers of the reactive IgG relative to total IgG in the sera of SCID mice began to increase from one week after implantation of the tumor cells, and became 10- to 100-fold higher than that in the donor's serum by 3-4 weeks. This model using implantation of human cancer cells in SCID mice reconstituted with human splenic tissues would facilitate further studies of human cancer immunology.

AB - Splenic tissues derived from patients with gastric cancer were implanted into mice with severe combined immunodeficiency (SCID) and then the mice were challenged with COLO-205, a human colon cancer cell line. Production of human immunoglobulin G (IgG) reactive against the COLO-205 cells was detected by enzyme-linked immunosorbent assay in sera from the reconstituted and tumor-bearing SCID mice. The titers of the reactive IgG relative to total IgG in the sera of SCID mice began to increase from one week after implantation of the tumor cells, and became 10- to 100-fold higher than that in the donor's serum by 3-4 weeks. This model using implantation of human cancer cells in SCID mice reconstituted with human splenic tissues would facilitate further studies of human cancer immunology.

KW - Human immunoglobulin

KW - SCID mouse

KW - Splenic tissue

UR - http://www.scopus.com/inward/record.url?scp=0026793529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026793529&partnerID=8YFLogxK

M3 - Article

VL - 83

SP - 894

EP - 898

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 8

ER -